Checkpoint Therapeutics SG&A Expense (Quarterly) Trends

Checkpoint Therapeutics Inc (CKPT)

2.01 +0.23 (+12.92%) USD | NASDAQ | May 20, 15:09

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	2.451M
December 31, 2023	1.876M
September 30, 2023	2.236M
June 30, 2023	2.281M
March 31, 2023	2.292M
December 31, 2022	2.482M
September 30, 2022	1.846M
June 30, 2022	2.129M
March 31, 2022	2.243M
December 31, 2021	2.128M
September 30, 2021	1.923M
June 30, 2021	2.114M
March 31, 2021	2.373M
December 31, 2020	2.124M
September 30, 2020	2.429M
June 30, 2020	1.687M
March 31, 2020	1.678M
December 31, 2019	2.152M

Date	Value
September 30, 2019	1.62M
June 30, 2019	1.758M
March 31, 2019	1.703M
December 31, 2018	1.502M
September 30, 2018	1.544M
June 30, 2018	1.352M
March 31, 2018	2.194M
December 31, 2017	1.355M
September 30, 2017	1.344M
June 30, 2017	1.317M
March 31, 2017	1.403M
December 31, 2016	1.09M
September 30, 2016	0.972M
June 30, 2016	1.221M
March 31, 2016	1.184M
December 31, 2015	2.156M
September 30, 2015	0.219M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.62M

Minimum

Sep 2019

2.482M

Maximum

Dec 2022

2.091M

Average

2.128M

Median

SG&A Expense (Quarterly) Benchmarks